StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)

Close on Nov 13, 2026Market cap $271.82MP/E –Yield –

ClearPoint Neuro total assets

Total assets on the balance sheet at the end of each period.

ClearPoint Neuro's total assets was $112.73M at Sep 30, 2026. For fiscal 2025 it was $97.75M, up 149.4% from the year before. Over ten years it grew 25.7% a year on average. The highest annual figure on record is $97.75M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$97.75M+149.4%
FY2024Dec 31, 2024$39.19M-8.1%
FY2023Dec 31, 2023$42.66M-23.1%
FY2022Dec 31, 2022$55.49M-15.4%
FY2021Dec 31, 2021$65.58M+122.2%
FY2020Dec 31, 2020$29.52M+147.5%
FY2019Dec 31, 2019$11.93M+51.8%
FY2018Dec 31, 2018$7.86M-43.5%
FY2017Dec 31, 2017$13.90M+87.8%
FY2016Dec 31, 2016$7.40M-25.5%
FY2015Dec 31, 2015$9.94M-25.8%
FY2014Dec 31, 2014$13.39M+70.0%
FY2013Dec 31, 2013$7.87M+41.8%
FY2012Dec 31, 2012$5.55M+83.2%
FY2011Dec 31, 2011$3.03M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$112.73M+86.8%
Q2 FY2026Jun 30, 2026$86.74M+38.0%
Q1 FY2026Mar 31, 2026$93.42M+210.7%
Q4 FY2025Dec 31, 2025$97.75M+149.4%
Q3 FY2025Sep 30, 2025$60.36M+50.2%
Q2 FY2025Jun 30, 2025$62.87M+19.6%
Q1 FY2025Mar 31, 2025$30.07M-43.9%
Q4 FY2024Dec 31, 2024$39.19M-8.1%
Q3 FY2024Sep 30, 2024$40.19M-8.3%
Q2 FY2024Jun 30, 2024$52.57M+10.4%
Q1 FY2024Mar 31, 2024$53.64M+6.7%
Q4 FY2023Dec 31, 2023$42.66M-23.1%
Q3 FY2023Sep 30, 2023$43.84M-24.1%
Q2 FY2023Jun 30, 2023$47.64M-20.9%
Q1 FY2023Mar 31, 2023$50.25M-18.7%
Q4 FY2022Dec 31, 2022$55.49M-15.4%
Q3 FY2022Sep 30, 2022$57.74M-16.0%
Q2 FY2022Jun 30, 2022$60.24M-16.7%
Q1 FY2022Mar 31, 2022$61.77M-16.8%
Q4 FY2021Dec 31, 2021$65.58M+122.2%
Q3 FY2021Sep 30, 2021$68.70M+214.5%
Q2 FY2021Jun 30, 2021$72.33M+214.0%
Q1 FY2021Mar 31, 2021$74.26M+214.9%
Q4 FY2020Dec 31, 2020$29.52M+147.5%
Q3 FY2020Sep 30, 2020$21.85M+63.2%
Q2 FY2020Jun 30, 2020$23.03M+73.6%
Q1 FY2020Mar 31, 2020$23.59M+209.3%
Q4 FY2019Dec 31, 2019$11.93M+51.8%
Q3 FY2019Sep 30, 2019$13.39M+54.3%
Q2 FY2019Jun 30, 2019$13.27M+14.5%
Q1 FY2019Mar 31, 2019$7.63M-38.2%
Q4 FY2018Dec 31, 2018$7.86M-43.5%
Q3 FY2018Sep 30, 2018$8.68M-43.9%
Q2 FY2018Jun 30, 2018$11.59M-31.2%
Q1 FY2018Mar 31, 2018$12.35M+99.5%
Q4 FY2017Dec 31, 2017$13.90M+87.8%
Q3 FY2017Sep 30, 2017$15.46M–
Q2 FY2017Jun 30, 2017$16.85M–
Q1 FY2017Mar 31, 2017$6.19M–
Q4 FY2016Dec 31, 2016$7.40M–

More ClearPoint Neuro figures

See a number that looks wrong?